pancpin Inhibitors
Pancpin inhibitors are a class of chemical compounds that target pancpin, a member of the serine protease inhibitor (serpin) family. Serpins are a group of proteins that regulate protease activity, ensuring that proteolytic enzymes are kept in balance within various biological processes, such as blood coagulation, inflammation, and cell migration. Pancpin, specifically, functions as an inhibitor of serine proteases, controlling their proteolytic activity in various tissues. By inhibiting pancpin, these compounds interfere with its ability to regulate serine protease activity, potentially affecting key biological pathways where precise protease control is essential, such as extracellular matrix remodeling and cellular signaling.
The inhibition of pancpin may occur through several mechanisms. Pancpin inhibitors could bind directly to pancpin, preventing it from forming inhibitory complexes with its target proteases, or they may alter its conformation, rendering it ineffective in controlling protease activity. These inhibitors are valuable tools for researchers studying the role of serine proteases in physiological processes, as well as the importance of protease regulation in maintaining cellular homeostasis. By manipulating pancpin function, scientists can explore how dysregulated protease activity affects processes such as tissue remodeling, wound healing, and the maintenance of the extracellular environment. Pancpin inhibitors also provide a means to dissect the complex interactions between serpins and proteases, offering insights into the fine balance of enzymatic activity required for normal cellular and molecular functioning.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound might induce demethylation of the SERPINI2 gene promoter, leading to the suppression of transcription factors binding and a consequent downregulation of pancpin expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylase activity, Trichostatin A could increase histone acetylation levels, which may lead to tight chromatin packaging at the SERPINI2 locus and a subsequent decrease in pancpin transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may intercalate into the DNA double helix, particularly at G-C rich regions, obstructing the advancement of RNA polymerase along the SERPINI2 gene, thereby curtailing the biosynthesis of pancpin mRNA. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
This compound might selectively inhibit RNA polymerase II, which is essential for mRNA synthesis, thus resulting in a specific decrease in the transcription of the pancpin-encoding gene, SERPINI2. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin can bind to FKBP12 and form a complex that inhibits mTOR, a key regulator of protein synthesis; this inhibition may lead to a global reduction in protein levels, including a potential decrease in pancpin expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB could inhibit the phosphorylation of the C-terminal domain of RNA polymerase II, which is necessary for the transition from initiation to elongation, potentially leading to a reduction in transcription of the pancpin gene. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to the minor groove of DNA, mithramycin A may block the binding of transcription factors to the promoter region of SERPINI2, thus specifically inhibiting the initiation of pancpin transcription. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Rocaglamide might inhibit the assembly of the eukaryotic initiation factor 4F complex on the 5' cap of mRNAs, thus leading to a selective decrease in the translation of mRNA species, possibly including those of pancpin. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin stabilizes the DNA-topoisomerase I complex during the S phase of the cell cycle, causing DNA breakage that can trigger DNA damage responses, potentially leading to the halting of pancpin expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
By raising the pH within cellular compartments like lysosomes, chloroquine might hamper the degradation pathway of mRNA, potentially resulting in a lessened stability and reduced levels of pancpin mRNA. | ||||||